Questionnaire survey on cardiologists' view and management of coronary microvascular disease in clinical practice

E Aribas1, S E Elias-Smale2, D J Duncker3

  • 1Department of Epidemiology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Insights

Dutch cardiologists recognize coronary microvascular disease (CMD) but lack guidelines. A significant majority expressed a strong need for a dedicated CMD guideline to improve diagnosis and treatment in clinical practice.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Clinical Practice

Background:

  • Coronary microvascular disease (CMD) presents diagnostic and therapeutic challenges in clinical practice.
  • Understanding cardiologists' perspectives on CMD is crucial for developing effective management strategies.

Purpose of the Study:

  • To assess Dutch cardiologists' opinions on coronary microvascular disease (CMD) and its management.
  • To determine the perceived need for a specific CMD guideline among Dutch cardiologists.

Main Methods:

  • An online questionnaire was developed and expert-reviewed.
  • The survey was distributed to all members of the Dutch Society of Cardiology.

Main Results:

  • 93% considered CMD diagnosis, 85% made the diagnosis, and 90% treated patients.
  • 58% viewed CMD as a distinct disease entity, with 61% believing evidence-based guidelines are lacking.
  • 82% of respondents strongly advocated for a new CMD guideline.

Conclusions:

  • A notable proportion of Dutch cardiologists recognize CMD as a separate entity and highlight the urgent need for a dedicated guideline.
  • The study emphasizes the necessity of a CMD guideline to standardize diagnosis and treatment in Dutch cardiology.
  • A low response rate (10%) suggests potential selection bias towards cardiologists with a pre-existing interest in CMD.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...